UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

VEGF-targeted therapy: mechanisms of anti-tumour activity

Nature reviews. Cancer, 2008-08, Vol.8 (8), p.579-591

2008

Volltextzugriff (PDF)

Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis

Journal of clinical oncology, 2005-02, Vol.23 (5), p.1011-1027

2005

Volltextzugriff (PDF)

Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology

Clinical cancer research, 2009-12, Vol.15 (24), p.7471-7478

2009

Volltextzugriff (PDF)

Pathways Mediating Resistance to Vascular Endothelial Growth Factor–Targeted Therapy

Clinical cancer research, 2008-10, Vol.14 (20), p.6371-6375

2008

Volltextzugriff (PDF)

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Cancer cell, 2005-10, Vol.8 (4), p.299-309

2005

Volltextzugriff (PDF)

Antiangiogenic therapy—evolving view based on clinical trial results

Nature reviews. Clinical oncology, 2012-05, Vol.9 (5), p.297-303

2012

Volltextzugriff (PDF)

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (3), p.1500-1508

2006

Volltextzugriff (PDF)

Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (8), p.3560-3564

2007

Volltextzugriff (PDF)

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

Cancer research (Chicago, Ill.), 2004-06, Vol.64 (11), p.3731-3736

2004

Volltextzugriff (PDF)

Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors

Science (American Association for the Advancement of Science), 2006-09, Vol.313 (5794), p.1785-1787

2006

Volltextzugriff (PDF)

CCR 20th Anniversary commentary: in search of cetuximab's first indication-combination therapy with irinotecan in colorectal cancer

Clinical cancer research, 2015-04, Vol.21 (7), p.1505-1507

Hicklin, Daniel J

2015

Volltextzugriff (PDF)

Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

The New England journal of medicine, 2008-03, Vol.358 (11), p.1109-1117

2008

Volltextzugriff (PDF)

Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4 + hemangiocytes

Nature medicine, 2006-05, Vol.12 (5), p.557-567

2006

Volltextzugriff (PDF)

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

Nature, 2005-12, Vol.438 (7069), p.820-827

2005

Volltextzugriff (PDF)

Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation

The Journal of clinical investigation, 2005-02, Vol.115 (2), p.247-257

2005

Volltextzugriff (PDF)

Granulocyte colony‐stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils

The FASEB journal, 2005-12, Vol.19 (14), p.2005-2007

2005

Volltextzugriff (PDF)

Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

Oncogene, 2005-04, Vol.24 (16), p.2647-2653

2005

Volltextzugriff (PDF)

The vascular endothelial growth factor receptor (VEGFR‐1) supports growth and survival of human breast carcinoma

International journal of cancer, 2006-10, Vol.119 (7), p.1519-1529

2006

Volltextzugriff (PDF)

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases

Cancer cell, 2004-12, Vol.6 (6), p.553-563

2004

Volltextzugriff (PDF)

Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells

Cancer research (Chicago, Ill.), 2006, Vol.66 (1), p.46-51

2006

Volltextzugriff (PDF)

Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression

Cancer immunology research, 2022-05, Vol.10 (5), p.581-596

2022

Volltextzugriff (PDF)

Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization

The Journal of experimental medicine, 2005-09, Vol.202 (6), p.739-750

2005

Volltextzugriff (PDF)

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: Implications for cellular surrogate marker analysis of antiangiogenesis

Cancer cell, 2005, Vol.7 (1), p.101-111

2005

Volltextzugriff (PDF)

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

Nature medicine, 2002-08, Vol.8 (8), p.831-840

2002

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Functions to Promote Uterine Decidual Angiogenesis during Early Pregnancy in the Mouse

Endocrinology (Philadelphia), 2009-08, Vol.150 (8), p.3845-3854

2009

Volltextzugriff (PDF)

1 – 25 von 250

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(240)
Mit Volltextzugriff
(223)

Publikationsform

Sprache

Englisch
(248)
Deutsch
(2)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(152)
Humans
(135)
Animals
(132)
Mice
(123)
Biological And Medical Sciences
(105)
Medical Sciences
(97)
Oncology
(88)
Antineoplastic Agents
(55)
Pharmacology. Drug Treatments
(54)
Tumors
(54)
Female
(52)
Mice, Nude
(45)
Antibodies, Monoclonal - Pharmacology
(43)
Male
(43)
Angiogenesis
(35)
Cell Line, Tumor
(33)
Antibodies, Monoclonal - Therapeutic Use
(32)
Receptors, Vascular Endothelial Growth Factor
(31)
Tumor Cells, Cultured
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(49)
Clinical Cancer Research
(24)
Blood
(15)
Nature Medicine
(9)
Journal For Immunotherapy Of Cancer
(7)
The Journal Of Clinical Investigation
(6)
Cancer
(5)
Cancer Cell
(5)
Neurosurgery
(5)
Hepatology
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

VEGF-targeted therapy: mechanisms of anti-tumour activity

Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis

Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology

Pathways Mediating Resistance to Vascular Endothelial Growth Factor–Targeted Therapy

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Antiangiogenic therapy—evolving view based on clinical trial results

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors

CCR 20th Anniversary commentary: in search of cetuximab's first indication-combination therapy with irinotecan in colorectal cancer

Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4 + hemangiocytes

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation

Granulocyte colony‐stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils

Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

The vascular endothelial growth factor receptor (VEGFR‐1) supports growth and survival of human breast carcinoma

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases

Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells

Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression

Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: Implications for cellular surrogate marker analysis of antiangiogenesis

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Functions to Promote Uterine Decidual Angiogenesis during Early Pregnancy in the Mouse

Suchergebnisse filtern